MSD Partners’s Fibrocell Science Inc. FCSC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-138,592
Closed -$410K 29
2019
Q3
$410K Hold
138,592
0.06% 25
2019
Q2
$263K Hold
138,592
0.03% 25
2019
Q1
$267K Hold
138,592
0.03% 24
2018
Q4
$208K Buy
138,592
+160
+0.1% +$320 0.02% 25
2018
Q3
$327K Sell
138,432
-160
-0.1% -$345 0.02% 34
2018
Q2
$375K Hold
138,592
0.02% 37
2018
Q1
$409K Hold
138,592
0.02% 30
2017
Q4
$443K Hold
138,592
0.02% 20
2017
Q3
$2.12M Hold
138,592
0.06% 29
2017
Q2
$2.78M Hold
138,592
0.17% 30
2017
Q1
$1.39M Hold
138,592
0.07% 31
2016
Q4
$1.31M Hold
138,592
0.07% 28
2016
Q3
$1.5M Hold
138,592
0.12% 26
2016
Q2
$2.39M Hold
138,592
0.16% 46
2016
Q1
$5.2M Buy
138,592
+3,881
+3% +$155K 0.27% 51
2015
Q4
$9.19M Buy
134,711
+1,535
+1% +$110K 0.39% 38
2015
Q3
$7.69M Buy
133,176
+18,000
+16% +$1.59M 0.25% 49
2015
Q2
$9.11M Hold
115,176
0.18% 54
2015
Q1
$7.79M Hold
115,176
0.18% 60
2014
Q4
$4.47M Hold
115,176
0.11% 55
2014
Q3
$5.01M Hold
115,176
0.15% 48
2014
Q2
$6.89M Hold
115,176
0.18% 48
2014
Q1
$9.04M Sell
115,176
-3,891
-3% -$302K 0.34% 45
2013
Q4
$7.25M Hold
119,067
0.3% 49
2013
Q3
$7.82M Buy
119,067
+33,334
+39% +$2.69M 0.29% 45
2013
Q2
$7.87M Buy
+85,733
New +$7.09M 0.43% 35

MSD Partners's FCSC Position: Q4 2019 in Review

MSD Partners sold out of Fibrocell Science Inc. (FCSC) in Q4 2019, closing a stake of 138,592 shares — an estimated $410K sold.

MSD Partners first reported a position in FCSC in Q2 2013 and held it in 26 quarters. The position peaked at $9.19M in Q4 2015. 0 funds tracked by Wall St. Rank hold FCSC as of Q4 2019.

  • MSD Partners reported no remaining Fibrocell Science Inc. position as of Q4 2019 after selling out during the quarter.
  • MSD Partners sold 138,592 Fibrocell Science Inc. shares in Q4 2019, an estimated $410K.
  • MSD Partners first reported a position in Fibrocell Science Inc. in Q2 2013 and held it in 26 quarters.
  • MSD Partners's Fibrocell Science Inc. position peaked at $9.19M in Q4 2015.
  • 0 funds tracked by Wall St. Rank held Fibrocell Science Inc. as of Q4 2019.

Based on MSD Partners's 13F filing for Q4 2019, filed 14 Feb 2020.